Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Auteurs : Robijns J, Nair RG, Lodewijckx J, Arany P, Barasch A, Bjordal JM, Bossi P, Chilles A, Corby PM, Epstein JB, Elad S, Fekrazad R, Fregnani ER, Genot MT, Ibarra AMC, Hamblin MR, Heiskanen V, Hu K, Klastersky J, Lalla R, Latifian S, Maiya A, Mebis J, Migliorati CA, Milstein DMJ, Murphy B, Raber-Durlacher JE, Roseboom HJ, Sonis S, Treister N, Zadik Y, Bensadoun RJ
Jaar : 2022
Journal : Front Oncol
Volume : 12
Pagina's : 927685

Editorial: Supportive care in cancer patients: quo vadis?

Auteurs : Klastersky J
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 257-258

Supportive care for cancer patients: a survey of available settings and current practices in Belgium.

Auteurs : Fontaine C, Echterbille MA, Klastersky J
Jaar : 2021
Journal : Support Care Cancer
Volume : 29
Pagina's : 5507-5512

Use of low-level laser therapy (LLLT) or photobiomodulation (PBM) for the management of the hand-foot syndrome (HSF) or palmo-plantar erythrodysesthesia (PPED) associated with cancer therapy.

Auteurs : Latifyan S, Genot-Klastersky MT, Fernez B, Scharll MF, Klastersky J
Jaar : 2020
Journal : Support Care Cancer
Volume : 28
Pagina's : 3287-3290

Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer.

Auteurs : Genot-Klastersky MT, Paesmans M, Ameye L, Kayumba A, Beauvois S, Dragan T, Van Gestel D, Lalami Y, Klastersky J
Jaar : 2020
Journal : Support Care Cancer
Volume : 28
Pagina's : 3015-3022

Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

Auteurs : Klastersky J, Dal Lago L, Lalami Y
Jaar : 2020
Journal : Curr Opin Oncol
Volume : 32
Pagina's : 258-261

Editorial: Supportive care: do we need a model?

Auteurs : Klastersky J
Jaar : 2020
Journal : Curr Opin Oncol
Volume : 32
Pagina's : 257

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.

Auteurs : Haltout J, Awada A, Paesmans M, Moreau M, Klastersky J, Machiels G, Ignatiadis M, Kotecki N
Jaar : 2019
Journal : Support Care Cancer
Volume : 27
Pagina's : 1163-1170

The close interrelation between colorectal cancer, infection and microbiota.

Auteurs : Massaut E, Hendlisz A, Klastersky J
Jaar : 2019
Journal : Curr Opin Oncol
Volume : 31
Pagina's : 362-367

Editorial: Supportive care in cancer patients: a constantly evolving field.

Auteurs : Klastersky J, Fontaine C
Jaar : 2019
Journal : Curr Opin Oncol
Volume : 31
Pagina's : 257-258

Development of the Multi-Dimensional Analysis of Patient Outcome Predictions (MD.POP) during medical encounters.

Auteurs : Ménard C, Libert Y, Canivet D, Van Achte L, Farvacques C, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Durieux JF, Klastersky J, Razavi D
Jaar : 2018
Journal : Patient Educ Couns
Volume : 101(1)
Pagina's : 52-58

The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategies.

Auteurs : Massaut E, Bohlok A, Lucidi V, Hendlisz A, Klastersky J, Donckier V
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pagina's : 262-268

Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinati

Auteurs : Rapoport BL, Aapro M, Paesmans M, van Eeden R, Smit T, Krendyukov A, Klastersky J
Jaar : 2018
Journal : BMC Cancer
Volume : 18
Pagina's : 917

Supportive care in cancer: quo vadis.

Auteurs : Klastersky J
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pagina's : 203-204

Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.

Auteurs : Awada G, Klastersky J
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(2)
Pagina's : 98-104

Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.

Auteurs : Bond TC, Szabo E, Gabriel S, Klastersky J, Tomey O, Mueller U, Schwartzberg L, Tang B
Jaar : 2018
Journal : J Oncol Pharm Pract
Volume : 24(6)
Pagina's : 412-423

Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data.

Auteurs : Lalami Y, Klastersky J
Jaar : 2017
Journal : Crit Rev Oncol Hematol
Volume : 120
Pagina's : 163-179

Concurrent driver mutations/rearrangements in non-small-cell lung cancer.

Auteurs : Tabchi S, Kourie HR, Klastersky J
Jaar : 2017
Journal : Curr Opin Oncol
Volume : 29(2)
Pagina's : 118-22

Predictors of physicians' communication performance in a decision-making encounter with a simulated advanced-stage cancer patient: A longitudinal study.

Auteurs : Libert Y, Canivet D, Ménard C, Van Achte L, Farvacques C, Merckaert I, Liénard A, Klastersky J, Reynaert C, Slachmuylder JL, Durieux JF, Delvaux N, Razavi D
Jaar : 2017
Journal : Patient Educ Couns
Volume : 100(9)
Pagina's : 1672-9

Old age: An extra risk for febrile neutropenia?

Auteurs : Klastersky J, Dal Lago L
Jaar : 2017
Journal : J Geriatr Oncol
Volume : 8(2)
Pagina's : 84-85